Evidence-Based Complementary and Alternative Medicine / 2018 / Article / Tab 2

Research Article

Efficacy and Safety of Hou Gu Mi Xi on Spleen Qi Deficiency in Patients with Nonorganic Gastrointestinal Disorders: Protocol for a Multicenter, Randomized, Placebo-Controlled Trial

Table 2

Procedures of the trial.

ItemBaseline week week week2 week5 week7 week10 week

Eligibility screening
Signed inform consent
Spleen Qi Deficiency Symptoms Grading and Quantifying Scale
Physical examination (height, weight, blood pressure, heart rate)
Blood, urine, and stool routine examination
Liver function (ALT, AST, TBIL, DBIL, IBIL)
Kidney function (Scr, BUN)
Gastric function (Gastrin-17)
Helicobacter Pylori
Record of adverse events
Compliance assessment

ALT = alanine transaminase, AST = aspartate aminotransferase, TBIL = total bilirubin, DBIL = direct bilirubin, IBIL = indirect bilirubin, SCr = serum creatinine, BUN = urea nitrogen, and PT= prothrombin time.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.